Efficacy of usage of pneumococcal 7-valent vaccine in prophylaxis of pneumococcal infection in Novosibirsk children from risk groups
In order to prevent children morbidity and mortality 116 children aged from 6 months to 5 years from 2 risk groups (1 - with bronchial-pulmonary dysplasia and 2 - with congenital heart defects) were vaccinated with pneumococcal 7-valent conjugated vaccine in 2011 at the expense of municipal budget....
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2013-03-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | In order to prevent children morbidity and mortality 116 children aged from 6 months to 5 years from 2 risk groups (1 - with bronchial-pulmonary dysplasia and 2 - with congenital heart defects) were vaccinated with pneumococcal 7-valent conjugated vaccine in 2011 at the expense of municipal budget. Among 116 children from both groups 16 (14%) have had community-acquired pneumonia, which is 22 times higher than in general children population in this region. Dynamic 1-year follow-up showed significant decrease of community-acquired pneumonia prevalence in risk groups: from 16/116 (14%) to 1/75 (1%) (p =0,006). There were no cases of invasive pneumococcal infections among vaccinated children and in 87,5% of them the general morbidity decreased. The frequency of moderate general post-vaccinal reactions was 1,8%, topical reactions - 0,9%. There were no other side effects during post-vaccinal period. Thereafter, the vaccination against pneumococcal infection performed in Novosibirsk in children with risk of fatal complications showed high efficacy and safety of the used vaccine. |
|---|---|
| Item Description: | 1682-5527 1682-5535 10.15690/vsp.v12i2.630 |